ABVC BioPharma, Inc.
ABVC • NASDAQ
ABVC BioPharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Uttam Yashwant Patil, with a market cap of $36.7M.
Market Cap$36.7M
Employees19.0
CEOUttam Yashwant Patil
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsApr 29, 2026 · In 2 weeksQ1 2026
Financials
ABVC BioPharma, Inc. FAQ
Common questions about ABVC BioPharma, Inc.
ABVC BioPharma, Inc. is scheduled to report earnings for Q1 2026 on April 29, 2026.
ABVC BioPharma, Inc. has approximately 19 employees.